百花医药：公司筹划控制权变更 股票继续停牌

Core Viewpoint - The company is planning a share transfer by its controlling shareholder, which may lead to a change in control of the company [1] Group 1 - The controlling shareholder and actual controller of the company are in the process of planning a share transfer agreement [1] - This share transfer may result in a change of control over the company [1] - To ensure fair information disclosure and protect investor interests, the company's stock will remain suspended from trading starting December 31, 2025, with an expected suspension period of no more than three trading days [1]